OPKO Health Net Profit Margin 2010-2023 | OPK
OPKO Health Net Profit Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Net Income | Net Margin |
2023-12-31 | $0.86B | $-0.19B | -21.76% |
2023-09-30 | $0.87B | $-0.21B | -23.88% |
2023-06-30 | $0.87B | $-0.21B | -24.08% |
2023-03-31 | $0.91B | $-0.29B | -31.87% |
2022-12-31 | $1.00B | $-0.33B | -32.67% |
2022-09-30 | $1.22B | $-0.32B | -25.98% |
2022-06-30 | $1.43B | $-0.20B | -14.17% |
2022-03-31 | $1.56B | $-0.12B | -7.45% |
2021-12-31 | $1.77B | $-0.03B | -1.69% |
2021-09-30 | $1.87B | $0.08B | 4.07% |
2021-06-30 | $1.91B | $0.07B | 3.72% |
2021-03-31 | $1.77B | $0.12B | 6.84% |
2020-12-31 | $1.44B | $0.03B | 2.16% |
2020-09-30 | $1.16B | $-0.11B | -9.71% |
2020-06-30 | $0.97B | $-0.20B | -20.62% |
2020-03-31 | $0.89B | $-0.29B | -32.92% |
2019-12-31 | $0.90B | $-0.32B | -34.96% |
2019-09-30 | $0.90B | $-0.28B | -31.03% |
2019-06-30 | $0.92B | $-0.25B | -26.63% |
2019-03-31 | $0.96B | $-0.19B | -19.94% |
2018-12-31 | $0.99B | $-0.15B | -15.44% |
2018-09-30 | $0.93B | $-0.30B | -31.72% |
2018-06-30 | $0.93B | $-0.30B | -32.72% |
2018-03-31 | $0.96B | $-0.31B | -32.88% |
2017-12-31 | $0.97B | $-0.31B | -31.68% |
2017-09-30 | $0.98B | $-0.13B | -12.81% |
2017-06-30 | $1.03B | $-0.10B | -10.12% |
2017-03-31 | $1.09B | $-0.07B | -6.50% |
2016-12-31 | $1.12B | $-0.05B | -4.30% |
2016-09-30 | $1.22B | $-0.01B | -0.74% |
2016-06-30 | $1.07B | $0.13B | 12.56% |
2016-03-31 | $0.75B | $0.08B | 9.97% |
2015-12-31 | $0.49B | $-0.03B | -6.11% |
2015-09-30 | $0.24B | $-0.09B | -35.27% |
2015-06-30 | $0.12B | $-0.26B | -222.03% |
2015-03-31 | $0.10B | $-0.24B | -244.00% |
2014-12-31 | $0.09B | $-0.17B | -186.96% |
2014-09-30 | $0.09B | $-0.14B | -156.32% |
2014-06-30 | $0.09B | $-0.15B | -167.05% |
2014-03-31 | $0.09B | $-0.13B | -142.05% |
2013-12-31 | $0.10B | $-0.12B | -118.56% |
2013-09-30 | $0.09B | $-0.10B | -107.61% |
2013-06-30 | $0.08B | $-0.05B | -59.04% |
2013-03-31 | $0.07B | $-0.06B | -82.61% |
2012-12-31 | $0.05B | $-0.03B | -65.96% |
2012-09-30 | $0.04B | $-0.01B | -32.43% |
2012-06-30 | $0.03B | $-0.01B | -34.38% |
2012-03-31 | $0.03B | $-0.01B | -20.00% |
2011-12-31 | $0.03B | $-0.00B | -10.71% |
2011-09-30 | $0.03B | $-0.02B | -75.86% |
2011-06-30 | $0.03B | $-0.02B | -75.00% |
2011-03-31 | $0.03B | $-0.02B | -81.48% |
2010-12-31 | $0.03B | $-0.02B | -75.00% |
2010-09-30 | $0.02B | $-0.03B | -157.89% |
2010-06-30 | $0.02B | $-0.03B | -213.33% |
2010-03-31 | $0.01B | $-0.03B | -310.00% |
2009-12-31 | $0.00B | $-0.04B | -875.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.906B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $218.674B | 26.50 |
Intuitive Surgical (ISRG) | United States | $137.856B | 83.04 |
DexCom (DXCM) | United States | $51.739B | 78.37 |
Edwards Lifesciences (EW) | United States | $51.727B | 33.66 |
IQVIA Holdings (IQV) | United States | $41.749B | 24.22 |
IDEXX Laboratories (IDXX) | United States | $39.946B | 46.82 |
Alcon (ALC) | Switzerland | $39.926B | 29.44 |
STERIS (STE) | Ireland | $21.035B | 24.90 |
Waters (WAT) | United States | $19.339B | 28.43 |
Hologic (HOLX) | United States | $17.760B | 19.87 |
SONOVA HOLDING (SONVY) | Switzerland | $17.524B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.408B | 77.22 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.801B | 13.77 |
Sysmex ADR (SSMXY) | Japan | $10.825B | 33.95 |
Teleflex (TFX) | United States | $9.492B | 14.77 |
Penumbra (PEN) | United States | $8.139B | 92.51 |
Masimo (MASI) | United States | $7.196B | 41.59 |
Globus Medical (GMED) | United States | $6.953B | 20.38 |
Glaukos (GKOS) | United States | $5.439B | 0.00 |
TransMedics (TMDX) | United States | $4.192B | 397.75 |
Integer Holdings (ITGR) | United States | $3.791B | 22.90 |
LivaNova (LIVN) | United Kingdom | $3.418B | 20.30 |
PROCEPT BioRobotics (PRCT) | United States | $3.229B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.842B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.783B | 19.09 |
Inari Medical (NARI) | United States | $2.489B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.426B | 20.52 |
RxSight (RXST) | United States | $2.300B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.976B | 8.62 |
Alphatec Holdings (ATEC) | United States | $1.899B | 0.00 |
Veracyte (VCYT) | United States | $1.608B | 0.00 |
Artivion (AORT) | United States | $0.979B | 95.08 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.897B | 17.45 |
Paragon 28 (FNA) | United States | $0.873B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.825B | 0.00 |
Silk Road Medical (SILK) | United States | $0.811B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.687B | 0.00 |
SiBone (SIBN) | United States | $0.646B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.621B | 21.09 |
IRadimed (IRMD) | United States | $0.553B | 30.99 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.520B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.509B | 0.00 |
Nevro (NVRO) | United States | $0.423B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
NeuroPace (NPCE) | United States | $0.382B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.343B | 11.74 |
Sight Sciences (SGHT) | United States | $0.281B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
AxoGen (AXGN) | United States | $0.255B | 0.00 |
AngioDynamics (ANGO) | United States | $0.246B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.213B | 0.00 |
Semler Scientific (SMLR) | United States | $0.198B | 10.09 |
908 Devices (MASS) | United States | $0.197B | 0.00 |
CVRx (CVRX) | United States | $0.175B | 0.00 |
Accuray (ARAY) | United States | $0.174B | 0.00 |
Inogen (INGN) | United States | $0.172B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.159B | 0.00 |
Delcath Systems (DCTH) | United States | $0.159B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.092B | 0.00 |
Neuronetics (STIM) | United States | $0.078B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.065B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.062B | 126.00 |
Yubo Biotech (YBGJ) | China | $0.058B | 0.00 |
Hyperfine (HYPR) | United States | $0.058B | 0.00 |
Envoy Medical (COCH) | United States | $0.056B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.053B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
InspireMD (NSPR) | Israel | $0.050B | 0.00 |
DarioHealth (DRIO) | United States | $0.048B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.039B | 0.00 |
LENSAR (LNSR) | United States | $0.037B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Spectral AI (MDAI) | United States | $0.030B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.021B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.018B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |